{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:01:03Z","timestamp":1783026063898,"version":"3.54.6"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00115-018-0643-9","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T11:34:33Z","timestamp":1542368073000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie","Therapeutic drug monitoring in neuropsychopharmacology"],"prefix":"10.1007","volume":"90","author":[{"given":"Stefan","family":"Unterecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Bergemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Willi","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Conca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Eckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Haen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Havemann-Reinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Helmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Jaquenoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Laux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainald","family":"M\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pfuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Saria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schoppek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarethe Silva","family":"Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Steimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Waschgler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Zernig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Zurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"643_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2004-832687","volume":"37","author":"P Baumann","year":"2004","unstructured":"Baumann P, Hiemke C, Ulrich S, Eckermann G et al (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243\u2013265","journal-title":"Pharmacopsychiatry"},{"key":"643_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0031-1286287","volume":"44","author":"C Hiemke","year":"2011","unstructured":"Hiemke C, Baumann P, Bergemann N, Conca A et\u00a0al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44:195\u2013235","journal-title":"Pharmacopsychiatry"},{"issue":"1\u201302","key":"643_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0037-1600991","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW et\u00a0al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1\u201302):e1. \n                    https:\/\/doi.org\/10.1055\/s-0037-1600991","journal-title":"Pharmacopsychiatry"},{"key":"643_CR4","first-page":"92","volume":"25","author":"G Hefner","year":"2018","unstructured":"Hefner G, Laux G, Baumann P et al (2018) Konsensus-Leitlinien f\u00fcr Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie: Update 2017. Psychopharmakotherapie 25:92\u2013140","journal-title":"Psychopharmakotherapie"},{"issue":"5","key":"643_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00115-008-2471-9","volume":"79","author":"E Haen","year":"2008","unstructured":"Haen E, Greiner C, Bader W, Wittmann M (2008) Wirkstoffkonzentrationsbestimmungen zur Therapieleitung. Nervenarzt 79(5):558\u2013566","journal-title":"Nervenarzt"},{"key":"643_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cpt.298","volume":"99","author":"SH Jang","year":"2016","unstructured":"Jang SH, Yan Z, Lazor JA (2016) Therapeutic drug monitoring: a patient management tool for precision medicine. Clin Pharmacol Ther 99:148\u2013150","journal-title":"Clin Pharmacol Ther"},{"key":"643_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/00007691-200404000-00010","volume":"26","author":"F Bengtsson","year":"2004","unstructured":"Bengtsson F (2004) Therapeutic drug monitoring of psychotropic drugs. TDM \u201enouveau\u201c. Ther Drug Monit 26:145\u2013151","journal-title":"Ther Drug Monit"},{"key":"643_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-0031-1286291","volume":"44","author":"KM Egberts","year":"2011","unstructured":"Egberts KM, Mehler-Wex C, Gerlach M (2011) Therapeutic drug monitoring in child and adolescent psychiatry. Pharmacopsychiatry 44:249\u2013253","journal-title":"Pharmacopsychiatry"},{"key":"643_CR9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00702-012-0952-2","volume":"120","author":"S Unterecker","year":"2013","unstructured":"Unterecker S, Riederer P, Proft F, Maloney J et\u00a0al (2013) Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions. J\u00a0Neural Transm (Vienna) 120:1237\u20131246","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"643_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00007691-200502000-00004","volume":"27","author":"DJ Touw","year":"2005","unstructured":"Touw DJ, Neef C, Thomson AH, Vinks AA et al (2005) Cost-effectiveness of therapeutic drug monitoring: a systematic review. Ther Drug Monit 27:10\u201317","journal-title":"Ther Drug Monit"},{"key":"643_CR11","first-page":"141","volume":"25","author":"G Laux","year":"2018","unstructured":"Laux G, Hiemke C, zur Capellen KM et al (2018) Therapeutisches Drug-Monitoring in psychiatrischen Versorgungskliniken. Psychopharmakotherapie 25:141\u2013147","journal-title":"Psychopharmakotherapie"},{"key":"643_CR12","first-page":"129","volume":"19","author":"E Haen","year":"2012","unstructured":"Haen E (2012) Der TDM-Befund. Psychopharmakotherapie 19:129\u2013134","journal-title":"Psychopharmakotherapie"},{"key":"643_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4088\/JCP.v68n0301","volume":"68","author":"S Leucht","year":"2007","unstructured":"Leucht S, Busch R, Kissling W, Kane JM (2007) Early prediction of antipsychotic nonresponse among patients with schizophrenia. J\u00a0Clin Psychiatry 68:352\u2013360","journal-title":"J Clin Psychiatry"},{"key":"643_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4088\/JCP.07m03780","volume":"70","author":"A Szegedi","year":"2009","unstructured":"Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E et al (2009) Early improvement in the first 2\u00a0weeks as a\u00a0predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J\u00a0Clin Psychiatry 70:344\u2013353","journal-title":"J Clin Psychiatry"},{"key":"643_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/joim.12317","volume":"277","author":"J Stingl","year":"2015","unstructured":"Stingl J, Viviani R (2015) Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. J\u00a0Intern Med 277:167\u2013177","journal-title":"J Intern Med"},{"issue":"5","key":"643_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00115-017-0310-6","volume":"88","author":"T Bschor","year":"2017","unstructured":"Bschor T, Baethge C, Hiemke C et\u00a0al (2017) Genetische Tests zur Steuerung der Behandlung mit Antidepressiva. Nervenarzt 88(5):495\u2013499","journal-title":"Nervenarzt"},{"key":"643_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/FTD.0b013e3182885d9d","volume":"35","author":"E Ostad Haji","year":"2013","unstructured":"Ostad Haji E, Mann K, Dragicevic A, M\u00fcller MJ et al (2013) Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram. Ther Drug Monit 35:396\u2013401","journal-title":"Ther Drug Monit"}],"updated-by":[{"DOI":"10.1007\/s00115-019-0766-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000}}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0643-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:08:23Z","timestamp":1600283303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0643-9"}},"subtitle":["Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP","Summary of the consensus guidelines 2017 of the TDM task force of the AGNP"],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0643-9","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00115-019-0766-7","asserted-by":"object"}]},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"16 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum zu:Nervenarzt 2018Im Originalbeitrag ist Tab.\u00a02 leider fehlerhaft. F\u00fcr die Substanzen Carbamazepin und Valproat wurde im Originalbeitrag ein Empfehlungsgrad zur Anwendung des therapeutischen Drug-Monitorings (TDM) von\u00a02 (empfohlen) angegeben. \u2026","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum zu:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Hiemke erhielt Honorare f\u00fcr Vortr\u00e4ge und Beratungen von den Firmen Janssen, Stada und Servier. Er ist Editor von PSIAC (), einem internetbasierten Arzneimittelinteraktionsprogramm.  P.\u00a0Baumann erhielt Honorare f\u00fcr Vortr\u00e4ge und Beratungen von nahezu allen pharmazeutischen Firmen, welche psychotrope Arzneistoffe in der Schweiz verkaufen.  E.\u00a0Haen ist Vorsitzender und leitender Direktor der AGATE (www.amuep-agate.de), Arbeitsgemeinschaft Arzneimitteltherapie bei psychiatrischen Erkrankungen. Er ist Editor von PSIAC (), einem internetbasierten Arzneimittelinteraktionsprogramm.  G.\u00a0Gr\u00fcnder diente als Berater f\u00fcr Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson und Otsuka. Er war Sprecher f\u00fcr Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Janssen Cilag, Otsuka, Pfizer, Servier und Wyeth. Er erhielt subventionierte Unterst\u00fctzung von Alkermes, Bristol-Myers Squibb, Eli Lilly und Johnson & Johnson. Er ist Mitbegr\u00fcnder von Pharma-Image \u2013 Molecular Imaging Technologies GmbH.  G.\u00a0Laux erhielt Honorare f\u00fcr Vortr\u00e4ge und Beratungen oder unbeschr\u00e4nkte Subventionen f\u00fcr Schulungen von Bayer, Janssen-Cilag, Lundbeck, Pfizer und Servier. G. Eckermann erhielt Honorare f\u00fcr Vortr\u00e4ge von den Firmen Axeleris, Germania, Janssen, neuraxpharm, Pfizer und Servier. Die restlichen Autoren geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}